| Literature DB >> 35157181 |
Berk Ozyilmaz1, Ozgur Kirbiyik2, Taha R Ozdemir2, Ozge Kaya Ozer2, Yasar B Kutbay2, Kadri M Erdogan2, Merve Saka Guvenc2, Şener Arıkan2, Tuba Sozen Turk2, Murat Yıldırım Kale3, Irem Fatma Uludag3, Figen Baydan4, Filiz Sertpoyraz5, Pinar Gencpinar6, Gulden Diniz7.
Abstract
Calpainopathy is mainly characterized by symmetric and progressive weakness of proximal muscles. Several reports showed that the most common LGMD subtype is LGMDR1 or calpainopathy, which had previously been defined as LGMD2A. Until now, more than 500 likely pathogenic/pathogenic variants in the CAPN3 gene have been reported. However, a clear genotype-phenotype association had not yet been established and this causes major difficulties in predicting the prognosis in asymptomatic patients and in providing genetic counseling for prenatal diagnosis. In this report, we aimed to add new data to the literature by evaluating 37 patients with likely pathogenic/pathogenic variants for the detected variants' nature, patients' phenotypes, and histopathological features. As a result, the general clinical presentation of the 23 different variants was presented, the high frequency of NM_000070.3:c.550delA mutation in Exon 4 was discussed, and some novel genotype-phenotype associations were suggested. We have underlined that calpainopathy can be misdiagnosed with inflammatory myopathies histopathologically. We have also emphasized that, in young or adult patients with mild to moderate proximal muscle weakness and elevated CK levels, calpainopathy should be the first suspected diagnosis.Entities:
Keywords: CAPN3; Calpainopathy; Histopathology; LGMD; NGS
Mesh:
Substances:
Year: 2022 PMID: 35157181 DOI: 10.1007/s10048-022-00687-4
Source DB: PubMed Journal: Neurogenetics ISSN: 1364-6745 Impact factor: 2.660